FDx Advisors Inc. Takes Position in Teleflex Incorporated (NYSE:TFX)

FDx Advisors Inc. bought a new position in shares of Teleflex Incorporated (NYSE:TFXFree Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 1,259 shares of the medical technology company’s stock, valued at approximately $305,000.

Other large investors have also bought and sold shares of the company. Qtron Investments LLC bought a new position in Teleflex during the 4th quarter worth $295,000. Kentucky Retirement Systems Insurance Trust Fund bought a new position in Teleflex during the 1st quarter worth $423,000. Mirova bought a new position in Teleflex during the 1st quarter worth $101,000. Raymond James Trust N.A. raised its position in Teleflex by 6.0% during the 1st quarter. Raymond James Trust N.A. now owns 2,155 shares of the medical technology company’s stock worth $546,000 after purchasing an additional 122 shares during the last quarter. Finally, US Bancorp DE raised its position in Teleflex by 3.7% during the 1st quarter. US Bancorp DE now owns 9,116 shares of the medical technology company’s stock worth $2,309,000 after purchasing an additional 322 shares during the last quarter. 97.15% of the stock is owned by institutional investors.

Teleflex Stock Performance

Shares of Teleflex stock opened at $196.41 on Friday. Teleflex Incorporated has a one year low of $182.65 and a one year high of $276.43. The firm has a market capitalization of $9.23 billion, a price-to-earnings ratio of 25.21, a PEG ratio of 2.11 and a beta of 1.03. The business has a 50-day simple moving average of $221.38 and a 200 day simple moving average of $238.92. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.60 and a quick ratio of 1.47.

Teleflex (NYSE:TFXGet Free Report) last issued its earnings results on Thursday, August 3rd. The medical technology company reported $3.41 EPS for the quarter, beating analysts’ consensus estimates of $3.21 by $0.20. Teleflex had a return on equity of 15.48% and a net margin of 12.71%. The business had revenue of $743.30 million during the quarter, compared to analyst estimates of $729.87 million. During the same period in the previous year, the company posted $3.39 EPS. The firm’s revenue was up 5.5% compared to the same quarter last year. On average, research analysts anticipate that Teleflex Incorporated will post 13.26 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 15th. Investors of record on Friday, September 15th were given a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.69%. The ex-dividend date of this dividend was Thursday, September 14th. Teleflex’s payout ratio is 17.46%.

Wall Street Analyst Weigh In

TFX has been the subject of several analyst reports. JMP Securities lowered their target price on Teleflex from $330.00 to $315.00 and set an “outperform” rating for the company in a research report on Friday, August 4th. Morgan Stanley reissued an “equal weight” rating and issued a $261.00 price objective on shares of Teleflex in a research report on Wednesday, July 19th. Raymond James lowered their price objective on Teleflex from $272.00 to $255.00 and set an “outperform” rating for the company in a research report on Monday, August 7th. Truist Financial lowered their price objective on Teleflex from $264.00 to $255.00 and set a “hold” rating for the company in a research report on Monday, August 7th. Finally, Stephens lifted their price objective on Teleflex from $305.00 to $315.00 in a research report on Thursday, July 27th. Eight analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $268.92.

Read Our Latest Research Report on Teleflex

About Teleflex

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Featured Stories

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.